Quest Partners LLC boosted its holdings in shares of Vital Farms, Inc. (NASDAQ:VITL - Free Report) by 882.6% during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 20,320 shares of the company's stock after acquiring an additional 18,252 shares during the period. Quest Partners LLC's holdings in Vital Farms were worth $713,000 as of its most recent filing with the Securities and Exchange Commission.
Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in VITL. Millennium Management LLC lifted its holdings in shares of Vital Farms by 651.3% in the second quarter. Millennium Management LLC now owns 494,153 shares of the company's stock valued at $23,112,000 after purchasing an additional 428,382 shares in the last quarter. Emerald Advisers LLC lifted its holdings in shares of Vital Farms by 106.8% in the third quarter. Emerald Advisers LLC now owns 706,440 shares of the company's stock valued at $24,775,000 after purchasing an additional 364,837 shares in the last quarter. Renaissance Technologies LLC lifted its holdings in shares of Vital Farms by 73.0% in the second quarter. Renaissance Technologies LLC now owns 784,153 shares of the company's stock valued at $36,675,000 after purchasing an additional 331,000 shares in the last quarter. Acadian Asset Management LLC lifted its holdings in shares of Vital Farms by 73.6% in the second quarter. Acadian Asset Management LLC now owns 679,504 shares of the company's stock valued at $31,766,000 after purchasing an additional 288,039 shares in the last quarter. Finally, Emerald Mutual Fund Advisers Trust bought a new stake in shares of Vital Farms in the second quarter valued at about $12,824,000. 98.59% of the stock is currently owned by institutional investors.
Vital Farms Price Performance
Shares of VITL traded down $0.59 during trading hours on Friday, reaching $30.44. The stock had a trading volume of 1,741,697 shares, compared to its average volume of 799,172. Vital Farms, Inc. has a 12 month low of $12.44 and a 12 month high of $48.41. The stock has a market capitalization of $1.33 billion, a PE ratio of 27.18 and a beta of 0.97. The company has a debt-to-equity ratio of 0.04, a quick ratio of 2.81 and a current ratio of 3.24. The company's 50-day moving average is $34.74 and its two-hundred day moving average is $36.72.
Vital Farms (NASDAQ:VITL - Get Free Report) last announced its quarterly earnings results on Thursday, November 7th. The company reported $0.16 EPS for the quarter, beating analysts' consensus estimates of $0.14 by $0.02. The company had revenue of $145.00 million during the quarter, compared to analysts' expectations of $145.27 million. Vital Farms had a return on equity of 22.29% and a net margin of 8.68%. Vital Farms's revenue was up 31.3% compared to the same quarter last year. During the same period in the prior year, the company earned $0.10 EPS. Research analysts expect that Vital Farms, Inc. will post 1.11 EPS for the current year.
Wall Street Analysts Forecast Growth
A number of analysts recently issued reports on the company. Jefferies Financial Group lowered their target price on Vital Farms from $45.00 to $41.00 and set a "buy" rating on the stock in a research report on Monday, November 11th. TD Cowen lowered their target price on Vital Farms from $46.00 to $41.00 and set a "buy" rating on the stock in a research report on Friday, November 8th. DA Davidson lifted their target price on Vital Farms from $44.00 to $48.00 and gave the company a "buy" rating in a research report on Thursday, October 10th. Finally, Stifel Nicolaus lowered their target price on Vital Farms from $42.00 to $34.00 and set a "hold" rating on the stock in a research report on Friday, August 9th. One analyst has rated the stock with a hold rating and five have given a buy rating to the company's stock. According to MarketBeat, the company currently has an average rating of "Moderate Buy" and an average target price of $39.20.
Get Our Latest Analysis on VITL
Insider Transactions at Vital Farms
In other news, insider Matthew Ohayer sold 24,000 shares of Vital Farms stock in a transaction dated Monday, October 21st. The stock was sold at an average price of $39.09, for a total value of $938,160.00. Following the completion of the transaction, the insider now directly owns 7,194,777 shares of the company's stock, valued at approximately $281,243,832.93. This trade represents a 0.33 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, CEO Russell Diez-Canseco sold 44,653 shares of the firm's stock in a transaction dated Monday, October 14th. The shares were sold at an average price of $40.07, for a total value of $1,789,245.71. Following the completion of the sale, the chief executive officer now owns 537,349 shares of the company's stock, valued at approximately $21,531,574.43. This represents a 7.67 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 27.60% of the company's stock.
Vital Farms Profile
(
Free Report)
Vital Farms, Inc, a food company, provides pasture-raised products in the United States. It offers shell eggs, butter, hard-boiled eggs, and liquid whole eggs. The company was founded in 2007 and is headquartered in Austin, Texas.
Featured Stories
Before you consider Vital Farms, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Vital Farms wasn't on the list.
While Vital Farms currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.